"China's next richest man will be born in the field of medical health." Ma Yun's words have become the best footnote for the madness of medical investment in the big health field. Recently, the “Global Famous Doctor Face-to-face and Biodata Cantonese Business Dual Engine Plan Launching Ceremony†was held in Guangzhou, and several overseas medical projects sought the attention of domestic investors. Lin Gang, executive director of SMI Swiss Medical Investment International Group in China and director of the Delan Foundation, pointed out that high-end medical services are becoming a “window†for medical investment at home and abroad.
According to the Ministry of Civil Affairs, by the end of 2016, China’s elderly population over 60 years old will reach 216 million, accounting for 16.7% of the total population. The demand for old-age care and medical services under the aging of the population has increased dramatically. The traditional medical system, especially high-end medical care, is already in an overloaded state. As China's population ageing progresses, chronic diseases and major diseases frequently generate strong market demand. According to research data from the Boston Consulting Group, by 2020, China's medical technology market will rank second in the world. Among them, the middle class and affluent consumers will account for 59% of the total number of urban households. More and more people can pay higher fees for health care and rapidly promote the growth of demand for health care products and services.
According to statistics from relevant institutions, the big health industry will reach 8 trillion in the next five years. At present, the big health industry is on the cusp, the application of new technology and new models, the advancement of medical reform, the admission of venture capital and the M&A investment between medical giants are in full swing. However, how to invest in capital and how to ensure the security of wealth has become a hot topic in the industry.
Lin Gang, executive director of SMI Swiss Medical Investment International Group in China, pointed out that some medical investment projects in Europe and the United States were not willing to share in China. With the gradual strengthening of China and the economic downturn in Europe, many European and American project organizations are willing to Medical investment projects are shared in China, and we hope to use the Chinese market and capital to promote the deep development of the project. For domestic investors, now is a good opportunity.
According to industry analysis, there will be three growth hotspots in the future medical service industry, namely high-end medical services, specialist chains and general hospitals. Lin Gang is more optimistic about investment opportunities in the high-end medical services market. He pointed out that the above-mentioned old-age pension is an example, and both China and Europe and the United States have huge market demand. More importantly, in the background of big data and logistics applications, there is a lot of experience abroad for domestic reference. For example, there is a very successful home-based pension program in Europe, which separates the teams that are close to eating, living care and health care treatment, and realizes the streamlined service through the back-end computer programming, which greatly reduces the cost and improves the efficiency, which is worth learning in China.
For the current hot Internet medical investment in China, Lin Gang pointed out that Internet + medical care should be medical + Internet, medical care is the main body, and the Internet is just a tool. "At present, the Internet + medical investment boom in China is actually putting the cart before the horse. The capital is now found to be burning money. The profit model is nowhere to go. There are precedents in Europe." Lin Gang said that the first Internet medical listed company in Europe in 2013 It is gradually declining until it closes. The experience of this company is the common predicament of domestic medical investment. “If Chinese investors can understand this situation three or four years in advance, investment can make fewer detours.â€
It is reported that in Europe, BioData is the only officially recognized medical investment forum sponsored by the Swiss and French regional governments. It has been held for 11 consecutive years, bringing together and incubating dozens of top medical projects in Europe and America, including pacemakers and telemedicine robots. Etc., formed the world's leading ecological chain of medical investment. Biodata's dual-engine plan for Guangdong business is based on the “global famous doctor face-to-face†and “Biodata Medical Investment Club†as the two core contents to build a healthy and wealth platform for Guangdong Merchants Overseas Medical Investment.
colostomy pouch ostomy pouch stoma pouch urostomy pouch
Wenzhou Celecare Medical Instruments Co.,Ltd , https://www.wzcelecare.com